ACTRN12606000477527招募中2 期
A correlative study to test whether hyperbilirubinemia after oral rifampicin can predict for irinotecan toxicity in patients with metastatic colorectal cancer.
Dr Nimit Singhal0 个研究点目标入组 30 人开始时间: 2006年11月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 85 Years（—）
- 性别
- All
入选标准
- •1.Patients with metastatic CRC being considered for irinotecan therapy. 2.Able to consent.3.Normal bilirubin; SGOT and SGPT = 3 times upper limit normal in absence of liver metastases or = 5 times upper limit normal in presence of liver metastases. 4.No prior exposure to irinotecan.
排除标准
- •1.Known hypersensitivity to Rifampicin. 2.Presence of jaundice or hyperbilirubinemia.3.Pregnancy.4.Concomitant infection with tuberculosis or leprosy. 5.Patients on treatment with saquinavir and ritonavir.There will be no age or gender restrction.
研究者
相似试验
招募中
不适用
A clinical trial to study the role of increased serum total bilirubin level as a new tool to detect complicated appendicitis.CTRI/2019/05/018879Bankura Sammilani Medical College and hospital
尚未招募
Unknown
to check the effect of bilirubin and albumin ratio with duration of phototherapyCTRI/2024/07/070378Datta Meghe Institute of Higher Education and Research
进行中（未招募）
不适用
Hyperbilirubinemia, the favourable side effect of atazanavir? Influence of atazanavir treatment on endothelial dysfunction, vascular inflammation and heme oxygenase activity in type 2 diabetes mellitus. - Hyperbilirubinemia, the favourable side effect of atazanavir?Type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathyEUCTR2008-000771-17-NLRUNMC
终止
不适用
Conjugated Hyperbilirubinemia and Pulse OximetryLiver DiseaseHyperbilirubinemiaNCT00741117Emory University4
尚未招募
不适用
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.Jaundice, NeonatalPrematureROPVery Low Birth Weight InfantELBW - Extremely Low Birth Weight InfantBlindnessNCT05806684Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1,586